Zobrazeno 1 - 10
of 95
pro vyhledávání: '"Marco, Valgimigli"'
Autor:
Giuseppe, Gargiulo, Daniele, Giacoppo, Sanjit S, Jolly, John, Cairns, Michel, Le May, Ivo, Bernat, Enrico, Romagnoli, Sunil V, Rao, Maarten A H, van Leeuwen, Shamir R, Mehta, Olivier F, Bertrand, George A, Wells, Thomas A, Meijers, George C M, Siontis, Giovanni, Esposito, Stephan, Windecker, Peter, Jüni, Marco, Valgimigli
Publikováno v:
Circulation. 146:1329-1343
Background: In some randomized clinical trials, transradial access (TRA) compared with transfemoral access (TFA) was associated with lower mortality in patients with coronary artery disease undergoing invasive management. We analyzed the effects of T
Autor:
Antonio Landi, Mattia Branca, Pascal Vranckx, Sergio Leonardi, Enrico Frigoli, Dik Heg, Paolo Calabro, Giovanni Esposito, Gennaro Sardella, Carlo Tumscitz, Stefano Garducci, Giuseppe Andò, Ugo Limbruno, Paolo Sganzerla, Andrea Santarelli, Carlo Briguori, Jose M. de la Torre Hernandez, Giovanni Pedrazzini, Stephan Windecker, Marco Valgimigli
Publikováno v:
Canadian Journal of Cardiology. 38:1488-1500
The comparative effectiveness of transradial (TRA) compared with transfemoral (TFA) access in acute coronary syndrome (ACS) patients undergoing complex percutaneous coronary intervention (PCI) remains unclear.Among 8404 ACS patients in the Minimising
Autor:
Samin K. Sharma, Carlo Andrea Pivato, Anne H. Tavenier, George Dangas, Kiyuk Chang, Frans Beerkens, Dominick J. Angiolillo, Marco Valgimigli, Mauro Chiarito, Samantha Sartori, Johny Nicolas, Davide Capodanno, Roxana Mehran, Usman Baber, Renicus S Hermanides, Jur ten Berg, Davide Cao, Annapoorna Kini, Arnoud W J van 't Hof, Matteo Nardin
Publikováno v:
European Heart Journal-Cardiovascular Pharmacotherapy, 8(5), 492-502. Oxford University Press
Aim Optimal dual antiplatelet therapy (DAPT) in patients undergoing percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS) intends to balance ischemic and bleeding risks. Various DAPT de-escalation strategies, defined as switching
Autor:
Masafumi Ono, Hironori Hara, Hideyuki Kawashima, Chao Gao, Rutao Wang, Joanna J. Wykrzykowska, Jan J. Piek, Scot Garg, Christian Hamm, Philippe Gabriel Steg, Marco Valgimigli, Stephan Windecker, Pascal Vranckx, Yoshinobu Onuma, Patrick Serruys Serruys
Publikováno v:
Eurointervention, 18, E377-e388
Eurointervention, 18(5), E377-E388. EUROPA EDITION
EuroIntervention, 18(5), e377-e388. EuroPCR
Eurointervention, 18, 5, pp. E377-e388
Eurointervention, 18(5), E377-E388. EUROPA EDITION
EuroIntervention, 18(5), e377-e388. EuroPCR
Eurointervention, 18, 5, pp. E377-e388
Background: The optimal antiplatelet strategy in the second year after percutaneous coronary intervention (PCI) remains unclear.Aims: We aimed to compare ticagrelor monotherapy with aspirin monotherapy on clinical outcomes beyond 1 year post-PCI.Meth
Autor:
Marco, Valgimigli, Enrico, Frigoli, Dik, Heg, Jan, Tijssen, Peter, Jüni, Pascal, Vranckx, Yukio, Ozaki, Marie-Claude, Morice, Bernard, Chevalier, Yoshinobu, Onuma, Stephan, Windecker, Pim A L, Tonino, Marco, Roffi, Maciej, Lesiak, Felix, Mahfoud, Jozef, Bartunek, David, Hildick-Smith, Antonio, Colombo, Goran, Stanković, Andrés, Iñiguez, Carl, Schultz, Ran, Kornowski, Paul J L, Ong, Mirvat, Alasnag, Alfredo E, Rodriguez, Aris, Moschovitis, Peep, Laanmets, Michael, Donahue, Sergio, Leonardi, Pieter C, Smits, Nguyen Ngoc, Quang
Publikováno v:
New England journal of medicine, 385(18), 1643-1655. Massachussetts Medical Society
The appropriate duration of dual antiplatelet therapy in patients at high risk for bleeding after the implantation of a drug-eluting coronary stent remains unclear.One month after they had undergone implantation of a biodegradable-polymer sirolimus-e
Autor:
Ran Kornowski, Mirvat Alasnag, Carl Schultz, Dik Heg, David Hildick-Smith, Peter Jüni, Bernard Chevalier, Andrés Iñiguez, Yoshinobu Onuma, Felix Mahfoud, Master Dapt investigators, Marco Roffi, Marie-Claude Morice, Goran Stankovic, Antonio Colombo, Enrico Frigoli, Alfredo E. Rodriguez, Aris Moschovitis, Maciej Lesiak, Stephan Windecker, Pim A.L. Tonino, Paul Jau Lueng Ong, Pieter C. Smits, Marco Valgimigli, Pascal Vranckx, Jozef Bartunek, Yukio Ozaki, Jan G.P. Tijssen, Peep Laanmets
Publikováno v:
Smits, Pieter C; Frigoli, Enrico; Tijssen, Jan; Jüni, Peter; Vranckx, Pascal; Ozaki, Yukio; Morice, Marie-Claude; Chevalier, Bernard; Onuma, Yoshinobu; Windecker, Stephan; Tonino, Pim A L; Roffi, Marco; Lesiak, Maciej; Mahfoud, Felix; Bartunek, Jozef; Hildick-Smith, David; Colombo, Antonio; Stankovic, Goran; Iñiguez, Andres; Schultz, Carl; ... (2021). Abbreviated Antiplatelet Therapy in Patients at High Bleeding Risk With or Without Oral Anticoagulant Therapy After Coronary Stenting: An Open-Label, Randomized, Controlled Trial. Circulation, 144(15), pp. 1196-1211. Lippincott Williams & Wilkins 10.1161/CIRCULATIONAHA.121.056680
Circulation
Circulation, 144(15), 1196-1211. Lippincott Williams and Wilkins
Circulation
Circulation, 144(15), 1196-1211. Lippincott Williams and Wilkins
Supplemental Digital Content is available in the text.
Background: The optimal duration of antiplatelet therapy (APT) in patients at high bleeding risk with or without oral anticoagulation (OAC) after coronary stenting remains unclear. Methods:
Background: The optimal duration of antiplatelet therapy (APT) in patients at high bleeding risk with or without oral anticoagulation (OAC) after coronary stenting remains unclear. Methods:
Autor:
Deepak L. Bhatt, Stefan H. Hohnloser, Philippe Gabriel Steg, Marco Valgimigli, Corinna Miede, Jonas Oldgren, Matias Nordaby, Jurriën M. ten Berg, Francesco Costa, Christopher P. Cannon, Gregory Y.H. Lip
Publikováno v:
European Heart Journal - Cardiovascular Pharmacotherapy. 8:216-226
Aims Patients with atrial fibrillation undergoing coronary intervention are at higher bleeding risk due to the concomitant need for oral anticoagulation and antiplatelet therapy. The RE-DUAL PCI trial demonstrated better safety with dual antithrombot
Autor:
Anastasios Roumeliotis, Sripal Bangalore, Ashok Seth, Marco Valgimigli, Ridhima Goel, Deepak L. Bhatt, Rishi Chandiramani, Moritz Blum, Junbo Ge, Franz-Josef Neumann, Lijuan Wang, Giulio G. Stefanini, James B. Hermiller, Roxana Mehran, Dominick J. Angiolillo, Davide Cao, Ken Kozuma, Kai Koo, Rajendra M Makkar, Mitchell W. Krucoff, Shigeru Saito
Publikováno v:
Catheterization and Cardiovascular Interventions. 98:1111-1119
Objective To investigate the impact of ischemic and bleeding risk factors on long-term clinical outcomes of patients with diabetes mellitus (DM) undergoing percutaneous coronary intervention (PCI) with everolimus-eluting stents. Background Second-gen
Autor:
Stephan Windecker, Davide Capodanno, Deepak L. Bhatt, Marco Valgimigli, Philip Urban, Dominick J. Angiolillo, Stefan James, Roxana Mehran, Sunil V. Rao, C. Michael Gibson, Takeshi Kimura, Philippe Gabriel Steg
For many years, bleeding has been perceived as an unavoidable consequence of strategies aimed at reducing thrombotic complications in patients undergoing percutaneous coronary intervention (PCI). However, the paradigm has now shifted towards bleeding
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f0c51c75dffb676621d7a9ffe2a97e5
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-464521
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-464521
Autor:
Philippe Gabriel Steg, Kees-Jan Royaards, Chao Gao, Rod Stables, Ply Chichareon, Rodrigo Modolo, Peter Jüni, Mariusz Tomaniak, Patrick W. Serruys, Christian W. Hamm, Chun Chin Chang, Angel Cequier, Marco Valgimigli, Yoshinobu Onuma, Robert-Jan van Geuns, Stephan Windecker, Keith G. Oldroyd, Kuniaki Takahashi, Norihiro Kogame
Publikováno v:
European heart journal. Cardiovascular pharmacotherapy, 6(1), 22-30. Oxford University Press
European Heart Journal. Cardiovascular pharmacotherapy, 6, 22-30. Oxford University Press
European Heart Journal. Cardiovascular pharmacotherapy, 6, 22-30. Oxford University Press
Aims The efficacy and safety of continued bivalirudin infusion after percutaneous coronary intervention (PCI) remains uncertain. We sought to investigate the association between post-PCI bivalirudin infusion and the risk of net adverse clinical event